Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Investors
Investor Welcome
Company Fact Sheet
ASX Announcements
Neuroprotection Program
Cardioprotection Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past Shareholder Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
>
Corporate Announcements
Investor Welcome
Company Fact Sheet
ASX Announcements
Neuroprotection Program
Cardioprotection Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past Shareholder Meetings
Corporate Announcements
5-Nov-2024
2024 AGM Addendum to the Notice of Meeting and Proxy
28-Oct-2024
Proposed issue of securities - NYR
28-Oct-2024
Proposed issue of securities - NYR
28-Oct-2024
Investor Presentation
28-Oct-2024
Nyrada Successfully Raises $3.36 Million via Placement
30-Sep-2024
2024 Annual General Meeting Access Letter, Notice and Proxy
22-Aug-2024
Annual Report for year ended 30 June 2024
27-May-2024
Upcoming Expiry of Unlisted Warrants
16-May-2024
Nyrada General Meeting Results
2-Apr-2024
2024 EGM Letter to Shareholders and Proxy
2-Apr-2024
2024 EGM Notice of Meeting and Proxy
6-Mar-2024
Nyrada Successfully Raises $1.755 Million via Placement
28-Feb-2024
Nyrada CEO James Bonner interview with 180 Markets
19-Jan-2024
Amended and Restated Certificate of Incorporation and Bylaws
8-Dec-2023
Nyrada Receives A$3.54M R&D Tax Incentive Rebate
20-Nov-2023
Nyrada Annual General Meeting Results
1-Nov-2023
2023 AGM Chair Letter to Shareholders
17-Oct-2023
2023 AGM Notice of Meeting and Proxy
17-Oct-2023
2023 AGM Letter to Shareholders and Proxy
28-Aug-2023
Annual Report for year ended 30 June 2023
28-Aug-2023
Appendix 4G and Corporate Governance Statement
20-Jul-2023
Nyrada Review of Operating Costs
26-Apr-2023
Quarterly Activities Report and Appendix 4C
16-Jan-2023
Notification of cessation of securities - NYR
21-Nov-2022
Results of Meeting
21-Nov-2022
AGM Presentation by James Bonnar CEO
21-Nov-2022
Nyrada AGM 2022 Chairmans Address
18-Nov-2022
Nyrada Receives A$1.2M R&D Tax Incentive Rebate
27-Oct-2022
CEO Remuneration Update
18-Oct-2022
2022 AGM Letter to Shareholders and Proxy
18-Oct-2022
2022 AGM Notice of Meeting and Proxy
2-Aug-2022
Nyrada Board Changes
2-Aug-2022
Initial Director's Interest Notice - GM
2-Aug-2022
Final Director's Interest Notice - PM
17-Jan-2022
Application for quotation of securities - NYR
17-Jan-2022
Change of Director's Interest Notice - ID
17-Jan-2022
Change of Director's Interest Notice - MF
17-Jan-2022
Change of Director's Interest Notice - RW
17-Jan-2022
Change of Director's Interest Notice - JM
17-Jan-2022
Change of Director's Interest Notice - CC
17-Jan-2022
Change of Director's Interest Notice - PM
12-Jan-2022
Nyrada Receives A$1.3M R&D Tax Incentive Rebate
10-Dec-2021
Release of Securities from Escrow
19-Nov-2021
Nyrada Annual General Meeting Results
19-Nov-2021
Annual General Meeting Presentation
19-Nov-2021
Nyrada AGM 2021 Chairman's Address
19-Oct-2021
2021 AGM Letter to Shareholders and Proxy
3-Sep-2021
Updated Share Trading Policy
30-Jun-2021
Change of Director's Interest Notice - CC
30-Jun-2021
Change of Director's Interest Notice - ID
30-Jun-2021
Change of Director's Interest Notice - RW
30-Jun-2021
Change of Director's Interest Notice - MF
30-Jun-2021
Change of Director's Interest Notice - PM
30-Jun-2021
Change of Director's Interest Notice - JM
30-Jun-2021
Change in substantial holding
30-Jun-2021
Change in substantial holding
29-Jun-2021
Cleansing Statement
29-Jun-2021
Confirmation of Capital Structure, CDIs on Issue
29-Jun-2021
Notification regarding unquoted securities - NYR
29-Jun-2021
Application for quotation of securities - NYR
29-Jun-2021
Application for quotation of securities - NYR
16-Jun-2021
Results of Meeting
11-May-2021
Notice of Extraordinary General Meeting/Proxy Form
6-May-2021
Nyrada Receives A$1.0M R&D Tax Incentive Rebate
26-Apr-2021
Change of Registered Office and Principal Place of Business
30-Mar-2021
Change in substantial holding
30-Mar-2021
Ceasing to be a substantial holder
30-Mar-2021
Change in substantial holding
30-Mar-2021
Cleansing Statement
30-Mar-2021
Appendix 2A
25-Mar-2021
Change in substantial holding
22-Mar-2021
Proposed issue of Securities - NYR
22-Mar-2021
Nyrada Receives Firm Commitments to Raise A$11 Million
17-Mar-2021
Trading Halt
5-Mar-2021
Change of Director's Interest Notice - JM
2-Mar-2021
Nyrada Newsletter February 2021
24-Feb-2021
Appendix 3G
24-Feb-2021
Change of Director's Interest Notice - MF
16-Feb-2021
Lapsing of balance of Unlisted SAB Options
16-Feb-2021
Cleansing Statement
16-Feb-2021
Appendix 2A
29-Jan-2021
Trading Halt
22-Jan-2021
Unlisted Scientific Advisory Board Options Expiry 15 Feb 21
18-Jan-2021
Change of Director's Interest Notice - ID
18-Jan-2021
Appendix 3G
18-Jan-2021
Appendix 3G
18-Jan-2021
Appendix 3G
7-Jan-2021
Release of Securities from Escrow
6-Jan-2021
Change in substantial holding
14-Dec-2020
Appointment of New Auditor
8-Dec-2020
Change in substantial holding
2-Dec-2020
Cleansing Statement
2-Dec-2020
Appendix 2A
26-Nov-2020
Change of Director's Interest Notice - JM
25-Nov-2020
Change of Director's Interest Notice - MF
25-Nov-2020
Appendix 2A
19-Nov-2020
Nyrada Annual General Meeting Results
19-Nov-2020
Presentation to 2020 Annual General Meeting of Shareholders
19-Nov-2020
Nyrada AGM 2020 Chairmans Address
16-Nov-2020
Release of Securities from Escrow
9-Nov-2020
Unlisted Convertible Note Options Expiring 30 November 2020
3-Nov-2020
2020 Annual General Meeting Reminder
19-Oct-2020
Letter to Shareholders and Proxy Form in relation to AGM
19-Oct-2020
Notice of Annual General Meeting and Proxy Form
24-Sep-2020
Nyrada Newsletter September 2020
17-Sep-2020
Notification of Date of 2020 Annual General Meeting
11-Sep-2020
Change of Director's Interest Notice - JM
9-Sep-2020
Nyrada Investor Webinar
8-Sep-2020
Initial Director's Interest Notice - ID
8-Sep-2020
Final Director's Interest Notice - GK
8-Sep-2020
Annual Report to 30 June 2020
8-Sep-2020
Appendix 4G and Corporate Governance Statement
31-Aug-2020
Nyrada Board Changes
8-Jul-2020
Change in substantial holding
25-Jun-2020
Nyrada Newsletter June 2020
27-Apr-2020
Change of Director's Interest Notice - JM
22-Apr-2020
Appointment of New Chief Financial Officer
20-Apr-2020
Preclinical Program & Corporate Update Global Webinar
6-Apr-2020
Nyrada Newsletter Released
16-Mar-2020
Update on Progress in Nyrada Programs
20-Jan-2020
Nyrada Inc - Chairman's letter to shareholders
20-Jan-2020
Becoming a substantial holder
16-Jan-2020
NOX: Listing of Nyrada Inc. spin-off on ASX
16-Jan-2020
NYR Commences Trading on the ASX
16-Jan-2020
Becoming a substantial holder
16-Jan-2020
Becoming a substantial holder
16-Jan-2020
Initial Director's Interest Notice
16-Jan-2020
Initial Director's Interest Notice
16-Jan-2020
Initial Director's Interest Notice
16-Jan-2020
Initial Director's Interest Notice
16-Jan-2020
Initial Director's Interest Notice
16-Jan-2020
Initial Director's Interest Notice
15-Jan-2020
Regulation S-Foreign Ownership Restrictions
14-Jan-2020
Confirmation and Waiver under ASX Listing Rules
14-Jan-2020
Pre-Quotation Disclosure
14-Jan-2020
Updated Pro-forma - Financial Position and Commitments
14-Jan-2020
Securities Trading Policy
14-Jan-2020
Capital Structure and Restricted Securities
14-Jan-2020
Financial Statements Year End 30 June 2019
14-Jan-2020
Financial Statements Year End 30 June 2018
14-Jan-2020
Corporate Governance Statement
14-Jan-2020
Equity Incentive Plan
14-Jan-2020
Amended and Restated Certificate of Incorporation and Bylaws
14-Jan-2020
Supplementary Prospectus
14-Jan-2020
Prospectus
14-Jan-2020
Appendix 1A, Information Form and Checklist, Annexure 3
14-Jan-2020
Distribution Schedule
14-Jan-2020
Top 20 Securityholders
14-Jan-2020
ASX Market Release - Admission and Quotation